SCHEMBL31468504

SCHEMBL31468504

C=C(c1ccccc1)c1ccc([Si](CCCN(C)C)(OCC)OCC)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
PDE1A P54750 6/20 0.36
PDE1B Q01064 6/20 0.36
PDE1C Q14123 6/20 0.36
ESR1 P03372 4/20 0.34
MAPT P10636 2/20 0.34
EGFR P00533 2/20 0.34
NPC1 O15118 1/20 0.34
NR1I2 O75469 1/20 0.34
PRKD3 O94806 1/20 0.34
ABCB11 O95342 1/20 0.34
GBA1 P04062 1/20 0.34
NR3C1 P04150 1/20 0.34
ERBB2 P04626 1/20 0.34
TP53 P04637 1/20 0.34
PRKCG P05129 1/20 0.34
CYP1A2 P05177 1/20 0.34
PRKCB P05771 1/20 0.34
LCK P06239 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31468468 0.89 KMT2A (0.37) MEN1KMT2AESR1MAPTEGFR
SCHEMBL31468459 0.88 MEN1 (0.36) MEN1KMT2ACYP1A2CHRM2CYP3A4
SCHEMBL31468625 0.87 MEN1 (0.43) MEN1KMT2APDE1APDE1BPDE1C
SCHEMBL31468522 0.87 MEN1 (0.45) MEN1KMT2APDE1APDE1BPDE1C
SCHEMBL28619621 0.81 MEN1 (0.42) MEN1KMT2AESR1MAPTNPC1
SCHEMBL31468562 0.80 KMT2A (0.46) MEN1KMT2APDE1APDE1BPDE1C
SCHEMBL31468539 0.79 MEN1 (0.37) MEN1KMT2ANR1I2CYP1A2CHRM2
SCHEMBL31468456 0.77 KMT2A (0.41) MEN1KMT2AESR1MAPTEGFR
SCHEMBL31468568 0.77 KMT2A (0.38) MEN1KMT2AESR1MAPTEGFR
SCHEMBL31468645 0.76 ALDH1A1 (0.34) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4541800-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME Shin-Etsu Chemical Co., Ltd. (JP) 2025-04-23 EP disclosed
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME HRH3, HRH4, OR10J3 MEN1 617/4885KMT2A 1539/4885PDE1A 4766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.